On November 8, 2024, the groundbreaking ceremony for Chongqing Precision Biotech Cell Technology R&D and Cell Preparation Center project was held in the Western Science City, Chongqing High-tech Zone. Leaders from the Chongqing High-tech Zone Management Committee, Science and Technology Bureau, Economic and Information Commission, and Food and Drug Administration were present to mark the occasion. Key figures from Zhifei Biotech, Zhirui Investment, and Precision Biotech, along with employee representatives and associated construction units, participated in the ceremony.

Professor Qian Cheng, chairman and chief scientist of the company, remarked that Precision Biotech Cell Technology Research Center and Cell Preparation Center project marks a significant milestone in the company’s journey. Based in Chongqing with a national focus, the project aims to transform precision medicine research outcomes, striving to establish a national R&D hub and an advanced manufacturing innovation center. It aims to build Precision Biotech into a global, innovative, and pioneering biopharmaceutical company, benefiting patients worldwide.

At the groundbreaking ceremony, Jia Hui, a member of the Party Working Committee of the Chongqing High-Tech Zone in the Western Science City and Deputy Director of the Management Committee of the Xiyong Comprehensive Bonded Zone, Xu Zhipeng, Deputy Secretary of the Party Committee of the Chongqing Science and Technology Bureau, and Wang Li, member of the Party Group and Deputy Director of the Chongqing Food and Drug Administration, offered sincere congratulations on the project’s groundbreaking. They also expressed earnest expectations for the company to accelerate research and development transformation and the smooth completion and operation of the project.Finally, Jiang Rensheng, chairman of Chongqing Zhifei Biological Products Co., Ltd., solemnly announced the start of the project’s groundbreaking.

The groundbreaking of Precision Biotech Cell Technology Research Center and Cell Preparation Center marks the company’s shift from new drug research and development to large-scale industrial applications, opening a new chapter. Upon completion, the facility will achieve an annual production capacity of 100,000 cell product preparations, enabling the company to overtake in the field of genetic and cell therapies nationally and even internationally. This will fuel the growth of the biopharmaceutical industry and inject new vitality into the development of new quality productivity.

Project Overview

Chongqing Precision Biotech Cell Technology R&D Center and Cell Preparation Center is strategically located in the core area of the Western Science City. It has a planned total investment of approximately 3 billion yuan, with 1.032 billion yuan allocated for construction. Spanning 154 acres, the facility will include 100,000 square meters of construction, housing a 30,000-square-meter technology research center and a 70,000-square-meter cell preparation center. This comprehensive project will focus on international innovation in genetic and cell technologies and drugs, featuring intelligent production and large-scale preparation capabilities.